search
Back to results

Quality of Analgesia After Interscalene Block After Arthroscopic Shoulder Surgery

Primary Purpose

Injury of Shoulder Region

Status
Completed
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
Exparel block in arthroscopic shoulder surgery
Bupivacaine block in shoulder surgery
Sponsored by
North American Institute for Continuing Medical Education (NAICE)
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Injury of Shoulder Region

Eligibility Criteria

18 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Dutch or English speaking adults
  • 18 years or older ASA I-III physical class
  • Scheduled for elective arthroscopic shoulder surgery

Exclusion Criteria:

  • History of allergy to a local anesthetic
  • Baseline neurological deficit
  • Medical condition that would make it difficult to assess sensory distribution or communicate with the investigators' staff
  • Recent history (< 3 months) of drug or alcohol abuse
  • Concomitant opioid therapy
  • Preexisting coagulation disorder
  • Infection at the injection site
  • Pregnancy

Sites / Locations

  • Department of Anesthesiology Ziekenhuis Oost-Limburg
  • Department of Anesthesiology ZOL

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Exparel block in arthroscopic surgery

Bupivacaine block in shoulder surgery

Arm Description

Evaluation of Exparel block in arthroscopic shoulder surgery.

Evaluation of Bupivacaine block in shoulder surgery.

Outcomes

Primary Outcome Measures

Worst pain
Satisfaction with analgesia

Secondary Outcome Measures

Onset of sensory block
Duration of sensory block
Onset of motor block
duration of motor block
functionality of the surgical arm

Full Information

First Posted
July 11, 2015
Last Updated
September 7, 2016
Sponsor
North American Institute for Continuing Medical Education (NAICE)
Collaborators
New York School of Regional Anesthesia, Pacira Pharmaceuticals, Inc
search

1. Study Identification

Unique Protocol Identification Number
NCT02554357
Brief Title
Quality of Analgesia After Interscalene Block After Arthroscopic Shoulder Surgery
Official Title
Quality of Analgesia After Interscalene Block With Bupivacaine and Exparel® vs. Bupivacaine Alone After Arthroscopic Shoulder Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
September 2016
Overall Recruitment Status
Completed
Study Start Date
July 2015 (undefined)
Primary Completion Date
January 2016 (Actual)
Study Completion Date
March 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
North American Institute for Continuing Medical Education (NAICE)
Collaborators
New York School of Regional Anesthesia, Pacira Pharmaceuticals, Inc

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Shoulder arthroscopic causes post operative pain that outlasts analgesia provided by single injection nerve blocks.
Detailed Description
The interscalene brachial plexus block (ISBPB) is a common analgesic technique for procedures of the shoulder and upper arm. Moreover, the incidence of rebound pain is well documented and is often of considerable discomfort to patients, who may quickly go from little or no pain to moderate-severe pain. Continuous nerve block techniques with home ambulatory catheters are currently utilized to manage postoperative pain.This study is designed to compare the level and duration of pain control of Exparel® injected after bupivacaine via stop-cock connected syringes and bupivacaine alone for ISBPB.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Injury of Shoulder Region

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Exparel block in arthroscopic surgery
Arm Type
Experimental
Arm Description
Evaluation of Exparel block in arthroscopic shoulder surgery.
Arm Title
Bupivacaine block in shoulder surgery
Arm Type
Experimental
Arm Description
Evaluation of Bupivacaine block in shoulder surgery.
Intervention Type
Drug
Intervention Name(s)
Exparel block in arthroscopic shoulder surgery
Other Intervention Name(s)
ISBPB with bupivacaine and Exparel
Intervention Description
The interscalene block will be performed with ultrasound guidance and nerve stimulation.
Intervention Type
Drug
Intervention Name(s)
Bupivacaine block in shoulder surgery
Other Intervention Name(s)
ISBPB with bupivacaine alone
Intervention Description
The interscalene block will be performed with ultrasound guidance and nerve stimulation.
Primary Outcome Measure Information:
Title
Worst pain
Time Frame
assessed by the Modified Brief Pain Inventory short form Question 1 in the first postoperative week - postoperative day (POD) 1 through POD7
Title
Satisfaction with analgesia
Time Frame
assessed by the Overall Benefit of Analgesia Score (OBAS) in the first postoperative week postoperative day (POD)1 through POD7
Secondary Outcome Measure Information:
Title
Onset of sensory block
Time Frame
onset will be measured up to 30 minutes
Title
Duration of sensory block
Time Frame
duration will be measured up to 72 hours
Title
Onset of motor block
Time Frame
onset will be measured up to 30 minutes
Title
duration of motor block
Time Frame
duration will be measured up to 72 hours
Title
functionality of the surgical arm
Time Frame
assessed on the scale 0-5 in the first postoperative week - postoperative day (POD) 2- POD7

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Dutch or English speaking adults 18 years or older ASA I-III physical class Scheduled for elective arthroscopic shoulder surgery Exclusion Criteria: History of allergy to a local anesthetic Baseline neurological deficit Medical condition that would make it difficult to assess sensory distribution or communicate with the investigators' staff Recent history (< 3 months) of drug or alcohol abuse Concomitant opioid therapy Preexisting coagulation disorder Infection at the injection site Pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Admir Hadzic, MD
Organizational Affiliation
Director
Official's Role
Study Director
Facility Information:
Facility Name
Department of Anesthesiology Ziekenhuis Oost-Limburg
City
Genk
Country
Belgium
Facility Name
Department of Anesthesiology ZOL
City
Genk
Country
Belgium

12. IPD Sharing Statement

Citations:
PubMed Identifier
28157791
Citation
Vandepitte C, Kuroda M, Witvrouw R, Anne L, Bellemans J, Corten K, Vanelderen P, Mesotten D, Leunen I, Heylen M, Van Boxstael S, Golebiewski M, Van de Velde M, Knezevic NN, Hadzic A. Addition of Liposome Bupivacaine to Bupivacaine HCl Versus Bupivacaine HCl Alone for Interscalene Brachial Plexus Block in Patients Having Major Shoulder Surgery. Reg Anesth Pain Med. 2017 May/Jun;42(3):334-341. doi: 10.1097/AAP.0000000000000560.
Results Reference
derived

Learn more about this trial

Quality of Analgesia After Interscalene Block After Arthroscopic Shoulder Surgery

We'll reach out to this number within 24 hrs